The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1281
March 10, 2008
View Complete Issue         Table of Contents 2019 
Gluten-Free Drugs for Celiac Disease Patients
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Gluten-Free Drugs for Celiac Disease Patients
March 10, 2008 (Issue: 1281)
Celiac disease is a chronic autoimmune disorder caused by a genetic intolerance to gluten that occurs in about 1% of the population. The main form of treatment is a lifelong gluten-free diet.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Gluten-Free Drugs for Celiac Disease Patients
Article code: 1281b
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.